Drugs / LECIG
last change Oct 2025 re-read 3 minutes ago

LECIG

Developed for
Parkinson disease
Investigated by
University Hospital Tuebingen

Trials 1

20262027202820292030
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT07151378 Oct 2025 → Sep 2030 expected Parkinson disease University Hospital Tuebingen Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as LECIG ClinicalTrials.gov intervention name — accepted as the source's own label NCT07151378 ↗